Travere Therapeutics (TVTX) PT Raised to $35 at Citi

February 24, 2025 4:58 AM

Citi analyst Carly Kenselaar raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $35.00 (from $31.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found